Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid
- PMID: 8068314
- DOI: 10.1006/biol.1994.1008
Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid
Abstract
The adjuvant activity of three adjuvants, aluminium phosphate (AIPO4), calcium phosphate (CaHPO4) and stearyl tyrosine for tetanus toxoid (TT) were compared to soluble TT in mice at a dose of 0.5 Lf (1/10th of the single human dose) and in guinea-pigs at a dose of 7.5 Lf (1.5 times the single human dose). Three TT preparations varying in purity were used: (1) ammonium sulphate precipitated formalin detoxified tetanus toxin (AS-TT); (2) AS-TT ultrafiltered to remove low molecular weight peptides (UF-TT): and (3) chromatographically purified tetanus toxin subsequently detoxified with formalin (CP-TT). After primary immunization of mice, AIPO4 absorbed TTs induced higher toxin-neutralizing and IgG (by ELISA) antibodies than CaHPO4, stearyl tyrosine adsorbed or soluble TT preparations, but this difference was no longer present after secondary immunization. TT preparations of varying purities showed similar antibody responses after primary and secondary immunizations when adsorbed on each adjuvant. CP-TT preparation showed the highest neutralizing antibody level amongst soluble preparations after the first dose. All the preparations induced mainly IgG1 antibodies. However, stearyl tyrosine adsorbed TT induced relatively higher IgG2a and IgG2b responses than AIPO4, CaHPO4 adsorbed or soluble TTs particularly after booster injection. No preparation induced detectable IgG3 or IgM antibodies. AIPO4 adsorbed preparations induced higher IgE antibodies than CaHPO4 and stearyl tyrosine adsorbed vaccines. Among the soluble preparations, CP-TT induced lower anti-TT IgE antibodies than standard AS-TT. All these preparations were also tested in the US potency test for adsorbed TT in guinea-pigs. While all the preparations passed this test, AIPO4 adsorbed TT preparations induced higher neutralizing and IgG antibodies than CaHPO4 and stearyl tyrosine adsorbed or soluble TT preparations. In these animal models, purified TT was a strong immunogen and traditional AIPO4 adjuvant gave the highest antibody responses.
Similar articles
-
Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.Dev Biol Stand. 1998;92:277-87. Dev Biol Stand. 1998. PMID: 9554282
-
Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.Vaccine. 1996 Feb;14(3):219-25. doi: 10.1016/0264-410x(95)00182-z. Vaccine. 1996. PMID: 8920703
-
Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid.Allergy. 1978 Jun;33(3):155-9. doi: 10.1111/j.1398-9995.1978.tb01527.x. Allergy. 1978. PMID: 707792
-
Calcium phosphate: a substitute for aluminum adjuvants?Expert Rev Vaccines. 2017 Mar;16(3):289-299. doi: 10.1080/14760584.2017.1244484. Epub 2016 Oct 24. Expert Rev Vaccines. 2017. PMID: 27690701 Review.
-
Adjuvant properties of aluminum and calcium compounds.Pharm Biotechnol. 1995;6:229-48. doi: 10.1007/978-1-4615-1823-5_8. Pharm Biotechnol. 1995. PMID: 7551219 Review.
Cited by
-
Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?Mol Cell Ther. 2013 Nov 6;1:2. doi: 10.1186/2052-8426-1-2. eCollection 2013. Mol Cell Ther. 2013. PMID: 26056568 Free PMC article. Review.
-
Transcutaneous antigen delivery system.BMB Rep. 2013 Jan;46(1):17-24. doi: 10.5483/bmbrep.2013.46.1.001. BMB Rep. 2013. PMID: 23351379 Free PMC article. Review.
-
Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.Mol Pharm. 2017 Sep 5;14(9):3228-3237. doi: 10.1021/acs.molpharmaceut.7b00586. Epub 2017 Aug 22. Mol Pharm. 2017. PMID: 28726424 Free PMC article.
-
Vaccine adjuvants: current challenges and future approaches.J Pharm Sci. 2009 Apr;98(4):1278-316. doi: 10.1002/jps.21523. J Pharm Sci. 2009. PMID: 18704954 Free PMC article. Review.
-
Novel adjuvants in allergen-specific immunotherapy: where do we stand?Front Immunol. 2024 Feb 23;15:1348305. doi: 10.3389/fimmu.2024.1348305. eCollection 2024. Front Immunol. 2024. PMID: 38464539 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous